Moreover, emerging markets often have large populations with limited access to advanced obesity treatments, positioning Tirzepatide to fill a critical gap in therapeutic options
Afamelanotide represents the historical first regulatory approval of a melanocortin analog for a pigmentation indication, clinically validating the peptide engineering strategy begun 30 years earlier
PE-22-28: PE-22-28 has limited safety data from preclinical studies
Retatrutide is a synthetic peptide developed to act as a triple receptor agonist
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information
We further demonstrate that this protective effect is partly mediated by specific body composition and metabolic factors, including linoleic acid using phenome-wide MR and mediation MR 23